| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/18/2009 | CN101385819A Medicine for treating the hemorrhoids and preparation method thereof |
| 03/18/2009 | CN101385767A Watermelon seeds oil soft capsules and preparation method thereof |
| 03/18/2009 | CN101385739A Medicine composition for improving the absorption of the anion polysaccharide |
| 03/18/2009 | CN101385724A Arginine Ibuprofen cream and preparation method thereof |
| 03/18/2009 | CN101385721A Percutaneous absorption transdermal enhancers |
| 03/18/2009 | CN101385718A Osmotic pump preparation composition for treating hyperlipemia |
| 03/18/2009 | CN101385715A Preparation method of novel hard-soluble medicine liposome |
| 03/18/2009 | CN101385712A Mouth spray for preventing and treating nausea and emesis after tumor chemotherapy and radiotheraphy and preparation method thereof |
| 03/18/2009 | CN101385711A Anticancer composition loaded with melphalan and lomustine |
| 03/18/2009 | CN101385710A Anticancer composition loaded with cyclophosphamide and carmustine |
| 03/18/2009 | CN101385709A Sustained-released injection containing carmustine of nitrosourea medicine |
| 03/18/2009 | CN101385708A Anti-cancer sustained-released agent containing fotemustine of nitrosourea medicine |
| 03/18/2009 | CN101385707A Anticancer composition loaded with melphalan and carmustine |
| 03/18/2009 | CN101385706A Anticancer composition loaded with melphalan and fotemustine |
| 03/18/2009 | CN101385705A Preparation method of aqueouse solution agent of minoplatin and other platinum complexes |
| 03/18/2009 | CN101385703A Cation adhesion type natamycin nano eye drops |
| 03/18/2009 | CN101385701A Anticancer composition loaded with norcantharidin and galamustine |
| 03/18/2009 | CN101385700A Anticancer composition loaded with 4H-peroxycyclophosphamide and nimustine |
| 03/18/2009 | CN101385699A Sustained-released injection containing nitrosourea medicine |
| 03/18/2009 | CN101385698A Anti-cancer sustained-released implantation agent |
| 03/18/2009 | CN101385696A Sodium alginate microspheres blood vessel suppository containing etoposide and preparation method and uses thereof |
| 03/18/2009 | CN100469794C Sp. PCC exocellular polysaccharide preparation and its uses as thickener and emulsifier |
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/18/2009 | CN100469788C 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives |
| 03/18/2009 | CN100469776C Amelioration of the development of cataracts and other ophthalmic diseases |
| 03/18/2009 | CN100469393C Sphingoid polyalkylamine conjugates for vaccination |
| 03/18/2009 | CN100469377C Soft capsule for treating prostatitis |
| 03/18/2009 | CN100469366C Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 03/18/2009 | CN100469360C Soft capsule of indapamide |
| 03/17/2009 | US7504477 Polyalkylene glycol acid additives |
| 03/17/2009 | US7504434 3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-dimer; viricide; influenza A or B infection, parainfluenza, mumps or Newcastle disease, myxovirus infections; stability; long time in lungs |
| 03/17/2009 | US7504409 Chronic obstructive pulmonary disease; asthma; respiratory system disorders; administering 2-aminonicotinic acid, anthranilic acid, bendroflumethiazide |
| 03/17/2009 | US7504383 metal at least partially enclosed by a discrete tubular, nanostructure composed of a plurality of aromatic homodipeptides |
| 03/17/2009 | US7504237 Polynucleotides encoding interferon gamma polypeptides |
| 03/17/2009 | US7504122 Coated food products containing hydrogenated indigestible starch syrup as a binding agent |
| 03/17/2009 | US7504114 Oxybutynin or fentanyl in a nonaqueous liquid having a solubility parameter of 7 to 13 (cal/cm3)1/2 and acetic acid or an acetate (sodium acetate); patches; excellent skin permeability |
| 03/17/2009 | US7504098 Method for introducing a biological molecule using a viral envelope and heparin and system therefore |
| 03/17/2009 | US7504097 Interferon-alpha polypeptides and conjugates |
| 03/17/2009 | US7504082 Magnetic nanoparticles comprising Gadolinium and method of fabrication |
| 03/17/2009 | CA2502731C Sustained release composition for oral administration of drugs |
| 03/17/2009 | CA2347925C Propofol composition |
| 03/17/2009 | CA2346863C Therapeutic use of polymers |
| 03/17/2009 | CA2309159C Skin penetration enhancing components |
| 03/17/2009 | CA2262073C Polymeric system for drug delivery and solute separation |
| 03/17/2009 | CA2258882C Compositions and methods for altering the biodistribution of biological agents |
| 03/17/2009 | CA2192438C Novel composition stimulating the cerebral activity and based on alkaloids having an eburnamenine nucleus, and preparation methods |
| 03/17/2009 | CA2171434C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 03/12/2009 | WO2009033039A2 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 03/12/2009 | WO2009032605A2 Bi-functional polymer-attached inhibitors of influenza virus |
| 03/12/2009 | WO2009032364A1 Activation of nuclear factor-kappa b |
| 03/12/2009 | WO2009032266A2 Dispersions of microparticles and microgels in hydrogels for drug delivery |
| 03/12/2009 | WO2009032171A1 Subcutaneous administration of alpha-galatosidase a |
| 03/12/2009 | WO2009031919A1 Alcoholism recurrence preventing agent and method for the use thereof |
| 03/12/2009 | WO2009031911A1 Cationic liposome carrier for genetic drugs |
| 03/12/2009 | WO2009031749A1 A novel controlled release-niacin formulation |
| 03/12/2009 | WO2009031682A1 EYE DROP COMPRISING DIBENZO[b,e]OXEPIN DERIVATIVE |
| 03/12/2009 | WO2009031644A1 Antifungal pharmaceutical composition |
| 03/12/2009 | WO2009031643A1 Antifungal composition |
| 03/12/2009 | WO2009031642A1 Pharmaceutical composition |
| 03/12/2009 | WO2009031577A1 Injection, injection solution and injection kit preparation |
| 03/12/2009 | WO2009031318A1 Preparation for external application comprising analgesic/anti-inflammatory agent |
| 03/12/2009 | WO2009031026A2 Lamivudine-cyclodextrin complex |
| 03/12/2009 | WO2009031006A2 Antiviral topical formulations in the form of a bio-adhesive gel |
| 03/12/2009 | WO2009030771A1 Peptides derivatized with a-b-c-d- and their therapeutical use |
| 03/12/2009 | WO2009030492A2 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 03/12/2009 | WO2009030481A1 Complexes of rna and cationic peptides for transfection and for immunostimulation |
| 03/12/2009 | WO2009030254A1 Complexes of rna and cationic peptides for transfection and for immunostimulation |
| 03/12/2009 | WO2009030205A2 Gelatine-active ingredient conjugates |
| 03/12/2009 | WO2009030066A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
| 03/12/2009 | WO2009030065A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 03/12/2009 | WO2009013435A3 Preservative-free prostaglandin-based ophthalmic solution |
| 03/12/2009 | WO2009012551A4 Resveratrol complex and process for the preperation |
| 03/12/2009 | WO2009010842A3 Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers |
| 03/12/2009 | WO2009010837A3 Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer |
| 03/12/2009 | WO2009009552A3 Preserving secondary peptide structure |
| 03/12/2009 | WO2009004495A3 Use of vhh antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications |
| 03/12/2009 | WO2008149230A3 Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate |
| 03/12/2009 | WO2008136850A3 Cobalamin conjugates useful as imaging and therapeutic agents |
| 03/12/2009 | WO2008135828A3 Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
| 03/12/2009 | WO2008106228A3 Methods and compositions for normalizing meibomian gland secretions |
| 03/12/2009 | WO2008094693A3 Compositions for aerosolization of highly conductive solutions |
| 03/12/2009 | WO2008040362A3 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 03/12/2009 | WO2008021619A3 Polymer particles including covalently bonded chemical species |
| 03/12/2009 | WO2008013807A9 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 03/12/2009 | WO2008012540A9 N-terminal polysialylation |
| 03/12/2009 | WO2005055975A3 Uv-stable semi-solid transdermal systems comprising a photosensitive active ingredient and a uv absorber |
| 03/12/2009 | US20090069449 Ethambutol based nitric oxide donors |
| 03/12/2009 | US20090069448 Degradable polymer and process for production thereof |
| 03/12/2009 | US20090069446 Dendritic salt therapeutic agent delivery system |
| 03/12/2009 | US20090069435 Bridged polycyclic compound based compositions for topical applications for pets |
| 03/12/2009 | US20090069411 Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
| 03/12/2009 | US20090069393 Parenteral formulation for epothilone analogs |
| 03/12/2009 | US20090069364 Pharmaceutical compositions of 5-alpha-reductase inhibitors and methods of use thereof |
| 03/12/2009 | US20090069220 Dna-binding polyamide drug conjugates |
| 03/12/2009 | US20090068758 Synthetic receptor |
| 03/12/2009 | US20090068277 Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom |
| 03/12/2009 | US20090068259 Controlled Surface Gelling of Mucoadhesive Polymers on Oral Mucosa |
| 03/12/2009 | US20090068252 Transdermal Absorption Preparation |
| 03/12/2009 | US20090068237 Dry eye treatment |
| 03/12/2009 | US20090068206 Delivery of pharmaceutical agents via the human insulin receptor |